Last Price$112.9(4.5%)
Market Cap$13.8B
LTM FCF to Net Income
187.2%
5Y avg
114.3%
Medical - Diagnostics & Research industry
median
86.7%
Stock quality & Intrinsic value
7/10
0.1% undervalued
Revvity, Inc. FCF to Net Income
Annual
Quarterly
LTM
Industry median
Company stand-alone
Crunching data... Almost there!
| Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FCF to Net Income | 275.1% | 69.4% | 120.1% | 138.1% | 126.2% | 96.1% | 111,656.3% | 160.4% | 72.3% | 156.7% | 121.1% | 147.8% | 158.9% | 91.7% | 123.9% | 111.9% | 140.6% | 102.6% | 5.5% | 200.3% |
Overvalued or undervalued?
Check the intrinsic value for RVTY
and see if it's the right time to invest.
Revvity, Inc. (RVTY) FCF to Net Income comparison analysis
General
LTM FCF to Net Income
OTHER METRICS
Company name
Revenue growth
EPS growth
Net Income margin
Revvity, Inc.RVTY
187.2%
0.2%
(58.6%)
9.8%
Median Peer Set
107.6%
2.1%
4.0%
15.6%
IQVIA Holdings Inc.IQV
154.0%
2.8%
2.4%
8.9%
ICON Public Limited CompanyICLR
141.1%
2.0%
28.7%
9.6%
Danaher CorporationDHR
135.8%
(0.1%)
(17.9%)
16.3%
Thermo Fisher Scientific Inc.TMO
114.7%
0.1%
6.8%
14.8%
Agilent Technologies, Inc.A
111.9%
(4.7%)
5.2%
19.8%
Quest Diagnostics IncorporatedDGX
103.3%
6.7%
2.8%
8.8%
Mettler-Toledo International Inc.MTD
100.2%
2.2%
12.7%
22.3%
Waters CorporationWAT
97.1%
0.1%
(1.1%)
21.6%
IDEXX Laboratories, Inc.IDXX
89.9%
6.5%
6.1%
22.8%
Natera, Inc.NTRA
(36.4%)
56.7%
(59.5%)
(11.2%)
RVTY key stats
USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
| Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
% growth | 1,473.8 (12.6%) | 1,546.4 4.9% | 1,787.3 15.6% | 1,937.5 8.4% | 1,812.2 (6.5%) | 1,704.3 (6.0%) | 1,921.3 12.7% | 2,115.2 10.1% | 2,166.2 2.4% | 2,237.2 3.3% | 2,262.4 1.1% | 2,115.5 (6.5%) | 2,257.0 6.7% | 2,778.0 23.1% | 2,883.7 3.8% | 3,782.7 31.2% | 5,067.2 34.0% | 3,311.8 (34.6%) | 2,750.6 (16.9%) | 2,755.0 0.2% |
| Cost of Goods Sold (COGS) | 859.3 | 918.3 | 1,062.6 | 1,107.4 | 1,032.4 | 945.7 | 1,070.7 | 1,152.0 | 1,189.3 | 1,232.6 | 1,237.9 | 1,102.2 | 1,184.0 | 1,437.1 | 1,487.6 | 1,672.9 | 2,215.9 | 1,322.0 | 1,210.9 | 1,217.4 |
% margin | 614.5 41.7% | 628.1 40.6% | 724.7 40.5% | 830.1 42.8% | 779.8 43.0% | 758.6 44.5% | 850.6 44.3% | 963.2 45.5% | 977.0 45.1% | 1,004.6 44.9% | 1,024.5 45.3% | 1,013.4 47.9% | 1,073.0 47.5% | 1,340.9 48.3% | 1,396.1 48.4% | 2,109.9 55.8% | 2,851.3 56.3% | 1,989.8 60.1% | 1,539.7 56.0% | 1,537.7 55.8% |
| Operating Expenses | 451.3 | 478.3 | 540.7 | 630.9 | 612.0 | 586.1 | 744.4 | 765.4 | 718.9 | 780.5 | 724.8 | 725.2 | 755.6 | 1,005.9 | 1,004.7 | 1,123.3 | 1,502.5 | 1,247.1 | 1,239.1 | 1,190.9 |
| Research & Development Expenses (R&D) | 87.4 | 99.7 | 111.6 | 108.1 | 107.3 | 95.4 | 115.8 | 132.6 | 133.0 | 121.1 | 125.9 | 124.3 | 139.4 | 194.0 | 189.3 | 205.4 | 275.0 | 221.6 | 216.6 | 196.8 |
| Selling, General & Administrative Expenses (SG&A) | 365.5 | 376.8 | 444.4 | 522.9 | 504.7 | 490.7 | 628.6 | 632.7 | 585.9 | 659.3 | 598.8 | 600.9 | 616.2 | 811.9 | 815.3 | 917.9 | 1,227.5 | 1,025.5 | 1,022.6 | 994.1 |
% margin | 234.3 15.9% | 153.4 9.9% | 168.2 9.4% | 193.0 10.0% | 147.6 8.1% | 153.6 9.0% | 89.7 4.7% | 195.7 9.3% | 217.4 10.0% | 210.7 9.4% | 286.1 12.6% | 283.1 13.4% | 304.8 13.5% | 323.9 11.7% | 362.0 12.6% | 978.6 25.9% | 1,332.4 26.3% | 742.7 22.4% | 300.6 10.9% | 346.7 12.6% |
| Interest Income | 0.0 | 0.0 | 0.0 | 4.0 | 1.0 | 0.8 | 1.9 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 2.6 | 1.1 | 1.5 | 1.0 | 2.2 | 3.6 | 72.1 | 73.2 |
| Interest Expense | 0.0 | 0.0 | 41.7 | 82.1 | 17.2 | 15.9 | 24.8 | 45.8 | 49.9 | 36.3 | 38.0 | 41.5 | 43.9 | 67.0 | 63.6 | 49.7 | 102.1 | 104.0 | 98.8 | 96.3 |
| Pre-tax Income | 66.7 | 150.7 | 151.3 | 147.4 | 130.7 | 162.0 | 62.9 | 50.6 | 153.3 | 169.6 | 244.0 | 244.1 | 296.7 | 257.7 | 237.1 | 906.4 | 1,279.9 | 651.8 | 183.0 | 316.1 |
% effective tax rate | 0.1 0.2% | 32.4 21.5% | 17.5 11.5% | 21.2 14.4% | 37.9 29.0% | 26.1 16.1% | 62.8 99.7% | (17.9) (35.3%) | (12.2) (8.0%) | 8.4 5.0% | 31.3 12.8% | 28.4 11.6% | 139.8 47.1% | 20.2 7.8% | 9.4 4.0% | 178.3 19.7% | 347.6 27.2% | 129.2 19.8% | 3.5 1.9% | 33.1 10.5% |
% margin | 66.5 4.5% | 119.6 7.7% | 131.7 7.4% | 126.4 6.5% | 85.6 4.7% | 135.9 8.0% | 0.2 0.0% | 69.9 3.3% | 167.2 7.7% | 157.8 7.1% | 212.4 9.4% | 234.3 11.1% | 156.9 7.0% | 237.9 8.6% | 227.6 7.9% | 727.9 19.2% | 943.2 18.6% | 569.2 17.2% | 693.1 25.2% | 270.4 9.8% |
| EPS | 0.51 | 0.96 | 1.11 | 1.07 | 0.74 | 1.16 | 0.00 | 0.61 | 1.49 | 1.40 | 1.89 | 2.14 | 1.43 | 2.15 | 2.05 | 6.53 | 8.12 | 4.51 | 5.56 | 2.30 |
| Diluted EPS | 0.51 | 0.95 | 1.09 | 1.07 | 0.73 | 1.15 | 0.00 | 0.61 | 1.47 | 1.39 | 1.87 | 2.12 | 1.42 | 2.13 | 2.04 | 6.49 | 8.08 | 4.50 | 5.55 | 2.20 |
% margin | 287.6 19.5% | 219.2 14.2% | 264.9 14.8% | 262.6 13.6% | 200.9 11.1% | 267.0 15.7% | 200.1 10.4% | 223.2 10.6% | 331.7 15.3% | 322.6 14.4% | 378.6 16.7% | 406.0 19.2% | 424.6 18.8% | 518.8 18.7% | 609.6 21.1% | 1,202.6 31.8% | 1,726.6 34.1% | 1,300.2 39.3% | 713.6 25.9% | 848.0 30.8% |
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
FAQ
1) What is Revvity, Inc.'s FCF to Net Income?
As of today, Microsoft Corp's last 12-month FCF to Net Income is 187.2%, based on the financial report for Dec 29, 2024 (Q4’2024). The average annual FCF to Net Income for Revvity, Inc. have been 107.3% over the past three years, and 120.0% over the past five years.
2) Is Revvity, Inc.'s FCF to Net Income Good?
As of today, Revvity, Inc.'s FCF to Net Income is 187.2%, which is higher than industry median of 86.7%. It indicates that Revvity, Inc.'s FCF to Net Income is Good.